By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.
ECTRIMS_Poster_2018_FLOODLIGHT: Smartphone-Based Self-Monitoring (SSM) is Accepted by Patients and Provides Meaningful, Continuous Digital Outcomes Consistent with and Augmenting Conventional In-Clinic Multiple Sclerosis Measures_Supplemental_Material
Oct 10, 2018
Supplemental Material for ECTRIMS_Poster_2018_FLOODLIGHT where data from the final analysis of adherence, results from a patient satisfaction questionnaire and correlations between in-clinic tests and FLOODLIGHT measures are reported.
